ArticleJournal of inflammation research2026
PD-L1 as a Potential Inducer for NF-κB Pathway Activation in M1-Type Macrophages During Sepsis: An Integrated Analysis Based on GEO Public Database and Multi-Omics Data.
Article in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: M1-type macrophages are a crucial defense line against pathogens during sepsis, and their polarization depends on NF-κB pathway activation. However, the specific molecular regulatory mechanisms of this process are not fully elucidated. Programmed death-ligand 1 (PD-L1), an important immune checkpoint molecule, is often anchored on the cell membrane exerting immunosuppressive effects, but its role in M1-type macrophages remains poorly understood. Methods: In this study, we preliminarily investigated the potential regulatory effect of PD-L1 on the NF-κB pathway in M1 macrophages by integrating GEO sepsis patient sequencing datasets, RNA-seq data from PD-L1-overexpressing M1 macrophages, immunoprecipitation-mass spectrometry (IP-MS), molecular docking, and co-immunoprecipitation (Co-IP). The Receiver Operating Characteristic (ROC) curve of PD-L1 was used as a prognostic indicator for sepsis. PD-L1 knockout mice were utilized to validate the in vivo regulatory effects of PD-L1. Results: Analysis of GEO data and peripheral blood mononuclear cells (PBMCs) from sepsis patients revealed significantly elevated PD-L1 expression with a central position among all upregulated genes. Furthermore, this elevated PD-L1 expression was validated in peripheral monocytes from sepsis patients compared to healthy controls. Single-gene GSEA analysis based on GEO data indicated a close association between PD-L1 and NF-κB pathway activation in sepsis patients. RNA-seq analysis of PD-L1-overexpressing M1 macrophages confirmed that PD-L1 significantly activates the NF-κB pathway. IP-MS screening and Co-IP validation identified an interaction between PD-L1 and KLF6, a nuclear factor closely related to the NF-κB pathway. Finally, liver transcriptome data from septic mice confirmed that PD-L1 can also activate the NF-κB pathway in vivo, and ROC curve analysis demonstrated PD-L1's potential as a prognostic indicator for sepsis. Conclusion: Based on these results, this study preliminarily reveals a potential activating role of PD-L1 on the NF-κB pathway in M1 macrophages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.